Akemi Coffee Boost’s formulation combines botanical extracts, dietary fibers and L-carnitine.
Company outlines seven listed ingredients, caffeine disclosure and scientific context while distinguishing individual-ingredient research from evidence on the finished coffee add-in
NEW YORK, September 17, 2026 — Akemi Coffee Boost has published an ingredient research and product transparency brief following the U.S. commercial introduction of its powdered beverage add-in, providing additional context on the seven ingredients listed in the formulation and the scientific literature associated with those individual components.
The new material is intended to distinguish between research involving individual botanical extracts, nutritional compounds and dietary fibers and evidence specifically evaluating the complete Akemi Coffee Boost formulation.
According to currently available product information, Akemi Coffee Boost is supplied in individual sachets intended to be mixed into beverages such as coffee, tea, water or smoothies. The formula lists green tea extract, green coffee bean extract, white kidney bean extract, mulberry leaf extract, L-carnitine L-tartrate, resistant dextrin and psyllium husk. Public product information also identifies approximately 30 mg of naturally occurring caffeine per sachet, attributed to the green coffee bean component.
The currently accessible product materials do not provide a complete per-ingredient milligram breakdown for the seven-component formula. As a result, studies using defined quantities of individual ingredients cannot be directly compared with the amount supplied by Akemi Coffee Boost.
“Our goal with this research summary is to provide context rather than convert ingredient studies into product claims,” said Michael Moore, Media Relations Manager at Akemi Coffee Boost. “An ingredient may have an established research history, but that does not automatically mean a multi-ingredient finished product has demonstrated the same result. Dosage, preparation, study population and formulation all matter when interpreting scientific literature.”
Akemi Coffee Boost Outlines Seven-Ingredient Formula
The product identifies the following seven ingredients:
-
Green tea extract
-
Green coffee bean extract
-
White kidney bean extract
-
Mulberry leaf extract
-
L-carnitine L-tartrate
-
Resistant dextrin
-
Psyllium husk
The combination brings together botanical extracts, an amino-acid-derived nutritional compound and dietary fiber ingredients in a powdered beverage format.
Akemi Coffee Boost’s existing product materials position the formula within the weight-management and everyday wellness supplement category. However, the company said its new research summary is intended to provide a more precise distinction between commercial product positioning and conclusions supported by direct clinical evidence.
No published randomized controlled clinical trial evaluating the complete Akemi Coffee Boost formulation was identified in the company materials reviewed for this announcement. Therefore, the research discussed below relates to the individual ingredients rather than to demonstrated outcomes from the complete product.
Green Tea Extract Has a Broad but Qualified Research Record
Green tea is derived from Camellia sinensis and contains naturally occurring compounds including catechins. Green tea beverages and concentrated extracts have been evaluated in a substantial body of nutritional research.
The National Center for Complementary and Integrative Health notes that green tea catechins and caffeine may have a modest influence on body weight in some research, while emphasizing that results can differ according to the composition of the product and other individual factors. NCCIH also states that definite conclusions have not been reached for many of the purposes for which green tea supplements are marketed.
This distinction is particularly important for concentrated extracts. Research evaluating a standardized preparation containing a specified quantity of catechins cannot automatically establish the characteristics of another green tea extract used at an unspecified amount.
The currently available Akemi Coffee Boost materials identify green tea extract as an ingredient but do not provide its individual amount or catechin standardization. Accordingly, the company does not present published green tea research as clinical evidence that the finished product produces a defined weight-management outcome.
Green Coffee Bean Research Illustrates Why Dosage Matters
Green coffee bean extract is produced from coffee beans before roasting and commonly contains chlorogenic acids in addition to naturally occurring caffeine.
Akemi Coffee Boost identifies green coffee bean extract as one component of its formulation and attributes approximately 30 mg of caffeine per sachet to that ingredient. The disclosure establishes a caffeine amount, but it does not disclose the amount of green coffee bean extract or chlorogenic acids contained in each serving.
A 2023 systematic review and meta-analysis examining green coffee bean extract containing chlorogenic acids included only three randomized controlled trials. The studies were small and short in duration, and the researchers noted the need for additional long-term research despite reporting changes in body weight within the studied populations.
The NIH Office of Dietary Supplements similarly characterizes available research on green coffee bean extract as limited, noting that relatively few clinical trials are available and that methodological quality has been a concern.
Those limitations make dose comparisons particularly important. Without a verified chlorogenic-acid amount or total green coffee extract quantity for Akemi Coffee Boost, research involving defined experimental preparations should not be represented as evidence for the finished sachet.
White Kidney Bean Extract Has Been Evaluated in Controlled Trials
White kidney bean extract, derived from Phaseolus vulgaris, is another listed botanical ingredient.
Certain preparations contain alpha-amylase inhibitors and have been studied in nutritional research involving carbohydrate digestion and body-composition measurements.
A 2026 systematic review and meta-analysis evaluated eight randomized controlled trials involving 543 adults with overweight or obesity. The analysis reported modest differences in several body-composition measures between white kidney bean extract and comparison groups. The authors nevertheless called for additional large, high-quality and longer-term trials to clarify its potential role.
These findings concern specific extracts administered under defined trial conditions.
Akemi Coffee Boost’s publicly accessible product information does not specify the quantity, standardization or alpha-amylase-inhibitor content of its white kidney bean extract. Therefore, the inclusion of this ingredient identifies a botanical with an existing research history but does not establish that the commercial formula provides the preparations or quantities evaluated in clinical trials.
Mulberry Leaf Research Has Produced Evolving Findings
Mulberry leaf has also been examined in human nutritional research.
A more recent systematic review and meta-analysis involving 12 clinical trials and 615 participants evaluated mulberry leaf or mulberry leaf extract in relation to several glycemic measurements. The authors reported changes in some measures across the included studies.
However, earlier systematic research reached more cautious conclusions. A 2016 review identified only three qualifying randomized trials and characterized the quality of the available studies as insufficient to determine whether mulberry leaf extract was useful for controlling glucose or lipid measurements in people with type 2 diabetes.
The difference between reviews illustrates why scientific evidence should not be reduced to a single headline result. Study populations, extract composition, methodology, dose and the quality of available trials can materially affect conclusions.
Akemi Coffee Boost lists mulberry leaf extract but does not disclose an individual amount in the accessible product information. The company therefore does not characterize research on specific mulberry preparations as direct evidence for its finished formula.
L-Carnitine L-Tartrate Provides a Nutritional Component
L-carnitine is a naturally occurring compound synthesized by the human body and obtained from some foods. L-carnitine L-tartrate is one form used in nutritional products.
According to the NIH Office of Dietary Supplements, carnitine plays an established biological role in transporting long-chain fatty acids into mitochondria, where they can be used in cellular energy production.
That biological role, however, should not be interpreted as evidence that consuming an unspecified amount of supplemental L-carnitine automatically produces fat loss or another particular body-composition outcome.
Clinical studies involving supplemental carnitine use specific forms, quantities, participant groups and durations. The accessible Akemi Coffee Boost materials do not disclose the quantity of L-carnitine L-tartrate per sachet, preventing a direct comparison with published research protocols.
For the new transparency brief, Akemi Coffee Boost therefore describes L-carnitine L-tartrate according to its established nutritional and biochemical context rather than presenting its inclusion as proof of a finished-product result.
Resistant Dextrin and Psyllium Husk Add Dietary Fiber Components
The formulation also includes resistant dextrin and psyllium husk, both used as sources of dietary fiber in nutritional products.
Psyllium is a soluble fiber that has been studied extensively in nutrition research. U.S. regulations permit certain health claims involving soluble fiber from qualifying foods containing psyllium when specific compositional and labeling requirements are satisfied. Those regulations relate to qualifying amounts and dietary context and should not be interpreted as automatically applying to every product that merely lists psyllium as an ingredient.
The same general principle applies when evaluating fiber research in relation to Akemi Coffee Boost.
The product materials reviewed identify resistant dextrin and psyllium husk among the seven ingredients but do not disclose their individual quantities. Without those amounts, it is not possible to establish whether the product supplies fiber quantities comparable to those investigated in specific nutritional studies.
Caffeine Disclosure Provides Additional Product Context
Akemi Coffee Boost’s existing product information reports approximately 30 mg of caffeine per sachet, attributed to green coffee bean extract.
Because the powder is designed to be added to coffee as well as other beverages, total caffeine exposure can depend on what beverage the consumer chooses. A sachet mixed into caffeinated coffee will contribute to caffeine already present in the drink, while use in water or another caffeine-free beverage would result in a different total.
The caffeine disclosure is therefore treated as product information rather than a performance claim.
Individual responses to caffeine vary, and consumers should take into account other dietary sources of caffeine when reviewing the product label.
Research on Individual Ingredients Does Not Establish Finished-Product Efficacy
The central conclusion of the company’s research brief is that ingredient research and finished-product research are different forms of evidence.
An individual compound may have been evaluated in dozens of studies, but those studies may use preparations and quantities that differ substantially from what appears in a commercial formula. Combining multiple researched ingredients also does not establish that their effects become additive or that the finished combination will reproduce findings observed when each ingredient was studied separately.
For Akemi Coffee Boost, this distinction is especially relevant because the complete individual-dose breakdown is not available in the currently accessible product information. The original company material likewise acknowledges that the absence of per-ingredient quantities limits direct comparisons with research protocols.
“Research transparency includes acknowledging what the available information cannot establish,” Moore said. “We can explain the scientific background of an ingredient without suggesting that every study involving that ingredient describes the performance of Akemi Coffee Boost. Product-specific evidence requires product-specific research.”
Product Format and U.S. Availability
Akemi Coffee Boost is supplied in individual powdered sachets. Company information instructs users to mix one sachet into a hot or cold beverage, including coffee, tea, water or a smoothie.
The product was introduced commercially in the United States in September 2026, with public company materials identifying the same seven ingredients and approximately 30 mg of caffeine per serving.
Current product specifications, serving directions and labeling should be confirmed against the physical package and current company materials.
Akemi Coffee Boost is marketed as a dietary supplement rather than a medicine. The company does not present the product as a substitute for a balanced diet, physical activity or professional medical care.
About Akemi Coffee Boost
Akemi Coffee Boost is a powdered dietary supplement offered in individual beverage-mix sachets. The formulation lists green tea extract, green coffee bean extract, white kidney bean extract, mulberry leaf extract, L-carnitine L-tartrate, resistant dextrin and psyllium husk. Company materials report approximately 30 mg of naturally occurring caffeine per sachet. Akemi Coffee Boost provides product information intended to distinguish ingredient-level scientific research from evidence specifically evaluating the finished formulation.
Media & Corporate Communications Contact
Michael Moore
Media Relations Manager
Akemi Coffee Boost
Mailing Address: 841 Fairmount Ave, Elizabeth, NJ 07201, USA
Email: support@buyakemicoffeeboost.com
Phone: +1 (888) 907-2458
Website: buyakemicoffeeboost.com
Regulatory Notice: Statements concerning dietary supplements have not been evaluated by the U.S. Food and Drug Administration. Akemi Coffee Boost is not intended to diagnose, treat, cure or prevent disease. Scientific studies discussed in this announcement concern individual ingredients and should not be interpreted as clinical testing of the complete Akemi Coffee Boost formulation.
